Company / CapEx per Share
X4 Pharmaceuticals, Inc CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.00 / $0.05
FY2021-FY2025
Trend
+1611.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +1612% YoY in FY2025, a notable deviation from the 4-year average annual change of +442%.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of -39.9%.
Declined from $0.05 to $0.01 over the past 3 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -39.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 1611.7% year-over-year.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +1611.7% |
| FY2024 | $0.00 | -98.7% |
| FY2022 | $0.05 | +353.8% |
| FY2021 | $0.01 | - |
| FY2020 | $0.00 | -100.0% |
| FY2018 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026